{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:06:49Z","timestamp":1775642809164,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00347-026-02418-8","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:59:06Z","timestamp":1774367946000},"page":"319-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nichtinfekti\u00f6se Uveitis im Kindesalter","Noninfectious uveitis in childhood"],"prefix":"10.1007","volume":"123","author":[{"given":"Uwe","family":"Pleyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"zur Bonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2418_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13113097","volume":"13","author":"M Modrzejewska","year":"2024","unstructured":"Modrzejewska\u00a0M, Zdanowska\u00a0O (2024) Diagnosis and treatment of uveitis in children: a\u00a0summary of the latest data from a\u00a05-year literature review (2018\u20132023). J\u00a0Clin Med 13:3097. https:\/\/doi.org\/10.3390\/jcm13113097","journal-title":"J Clin Med"},{"key":"2418_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03117-7","volume":"23","author":"W Wan","year":"2023","unstructured":"Wan\u00a0W, Chen\u00a0Z, Xun\u00a0Y, Yi\u00a0K, Zhu\u00a0Y, Pu\u00a0Y, Su\u00a0G, Zhou\u00a0C, Wang\u00a0Y, Yang\u00a0P (2023) Comprehensive evaluation of functional vision, quality of life, and cognitive ability in pediatric uveitis. BMC Ophthalmol 23:381. https:\/\/doi.org\/10.1186\/s12886-023-03117-7","journal-title":"BMC Ophthalmol"},{"key":"2418_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs\u00a0DA, Nussenblatt\u00a0RB, Rosenbaum\u00a0JT, SUN Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. AJO Int 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"2418_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/bjo.2004.050609","volume":"89","author":"D BenEzra","year":"2005","unstructured":"BenEzra\u00a0D, Cohen\u00a0E, Maftzir\u00a0G (2005) Uveitis in children and adolescents. Br J Ophthalmol 89:444\u2013448. https:\/\/doi.org\/10.1136\/bjo.2004.050609","journal-title":"Br J Ophthalmol"},{"key":"2418_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajo.2025.05.024","volume":"277","author":"Y Qian","year":"2025","unstructured":"Qian\u00a0Y, Xu\u00a0RH, Rabbani\u00a0JW, Tucker\u00a0LY (2025) Incidence and Predictors of Remission of Childhood Uveitis in a Large Community Cohort. AJO Int 277:221\u2013229. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.024","journal-title":"Am J Ophthalmol"},{"key":"2418_CR6","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1080\/09273948.2023.2282610","volume":"31","author":"P Maghsoudlou","year":"2023","unstructured":"Maghsoudlou\u00a0P, Abraham\u00a0AR, El-Ashry\u00a0M, Chew\u00a0C, Mohd\u00a0N, Ramanan\u00a0AV, Dick\u00a0AD (2023) Uveitis associated with monogenic autoinflammatory syndromes in children. Ocul Immunol Inflamm 31:1930\u20131943. https:\/\/doi.org\/10.1080\/09273948.2023.2282610","journal-title":"Ocul Immunol Inflamm"},{"key":"2418_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/14656566.2017.1361408","volume":"18","author":"U Pleyer","year":"2017","unstructured":"Pleyer\u00a0U, Algharably\u00a0EA, Feist\u00a0E, Kreutz\u00a0R (2017) Small molecules as therapy for uveitis: a selected perspective of new and developing agents. Expert Opin Pharmacother 18:1311\u20131323. https:\/\/doi.org\/10.1080\/14656566.2017.1361408","journal-title":"Expert Opin Pharmacother"},{"key":"2418_CR8","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.2147\/OPTH.S495307","volume":"18","author":"SRB Murugan","year":"2024","unstructured":"Murugan\u00a0SRB, Sanjay\u00a0S, Somanath\u00a0A, Mahendradas\u00a0P, Patil\u00a0A, Kaur\u00a0K, Gurnani\u00a0B (2024) Artificial intelligence in uveitis: innovations in diagnosis and therapy. Clin Ophthalmol 18:3753\u20133766. https:\/\/doi.org\/10.2147\/OPTH.S495307","journal-title":"Clin Ophthalmol"},{"key":"2418_CR9","unstructured":"Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C et\u00a0al (2021) Diagnostik und antientz\u00fcndliche Therapie der Uveitis bei juveniler idiopathischer Arthritis. AWMF-Leitlinie 045-012."},{"key":"2418_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00347-022-01691-7","volume":"120","author":"A Taghavi-Eraghi","year":"2023","unstructured":"Taghavi-Eraghi\u00a0A, Garweg\u00a0JG, Pleyer\u00a0U (2023) Diagnostik und Behandlung der okul\u00e4ren Toxoplasmose: Ergebnisse einer Umfrage. Ophthalmologie 120:191\u2013199. https:\/\/doi.org\/10.1007\/s00347-022-01691-7","journal-title":"Ophthalmologie"},{"key":"2418_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3238\/arztebl.2015.0092","volume":"112","author":"A Heiligenhaus","year":"2015","unstructured":"Heiligenhaus\u00a0A, Minden\u00a0K, F\u00f6ll\u00a0D, Pleyer\u00a0U (2015) Uveitis bei juveniler idiopathischer Arthritis. Dtsch Arztebl Int 112:92\u2013100. https:\/\/doi.org\/10.3238\/arztebl.2015.0092","journal-title":"Dtsch Arztebl Int"},{"key":"2418_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12969-025-01122-2","volume":"23","author":"X Peng","year":"2025","unstructured":"Peng\u00a0X, Liu\u00a0Q, Lin\u00a0L, Dong\u00a0L (2025) Incidence and risk factors of uveitis in children with JIA: meta-analysis. Pediatr Rheumatol Online J 23:71\u201371. https:\/\/doi.org\/10.1186\/s12969-025-01122-2","journal-title":"Pediatr Rheumatol"},{"key":"2418_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/978-3-662-60399-4_26","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"A Heiligenhaus","year":"2021","unstructured":"Heiligenhaus\u00a0A, Heinz\u00a0C, Kasper\u00a0M, Niewerth\u00a0M, Minden\u00a0K (2021) Juvenile idiopathische Arthritis und Uveitis. In: Pleyer\u00a0U (ed) Entz\u00fcndliche Augenerkrankungen. Springer, pp\u00a0527\u2013545"},{"key":"2418_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-024-01037-4","author":"AL Solebo","year":"2025","unstructured":"Solebo\u00a0AL, Foeldvari\u00a0I (2025) Reducing risk of visual disability in JIA-uveitis. Pediatr Rheumatol Online J. https:\/\/doi.org\/10.1186\/s12969-024-01037-4","journal-title":"Pediatr Rheumatol"},{"key":"2418_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bjo-2023-324406","volume":"109","author":"I Foeldvari","year":"2024","unstructured":"Foeldvari\u00a0I, Bohn\u00a0M, Petrushkin\u00a0H, Angeles-Han\u00a0S, Bangsgaard\u00a0R, Calzada-Hern\u00e1ndez\u00a0J et\u00a0al (2024) Practical approach to uveitis screening in JIA. Br J Ophthalmol 109:372\u2013379. https:\/\/doi.org\/10.1136\/bjo-2023-324406","journal-title":"Br J Ophthalmol"},{"key":"2418_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03531-w","volume":"27","author":"K Baquet-Walscheid","year":"2025","unstructured":"Baquet-Walscheid\u00a0K, Minden\u00a0K, Niewerth\u00a0M, Dressler\u00a0F, Foeldvari\u00a0I, Foell\u00a0D et\u00a0al (2025) Course of uveitis in JIA: ICON-JIA 5\u2011year follow-up. Arthritis Res Ther 27:61. https:\/\/doi.org\/10.1186\/s13075-025-03531-w","journal-title":"Arthritis Res Ther"},{"key":"2418_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00347-023-01960-z","volume":"121","author":"P Werkl","year":"2024","unstructured":"Werkl\u00a0P, Rademacher\u00a0J, Pleyer\u00a0U (2024) HLA-B27-positive vordere Uveitis: Klinische Aspekte, Diagnostik, interdisziplin\u00e4res Management und Behandlung. Ophthalmologie 121:12\u201322. https:\/\/doi.org\/10.1007\/s00347-023-01960-z","journal-title":"Ophthalmologe"},{"key":"2418_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells11","volume":"11","author":"LS Zur Bonsen","year":"2021","unstructured":"Zur Bonsen\u00a0LS, Pohlmann\u00a0D, R\u00fcbsam\u00a0A, Pleyer\u00a0U (2021) Findings and graduation of sarcoidosis-related uveitis. Cells 11:89. https:\/\/doi.org\/10.3390\/cells11","journal-title":"Cells"},{"key":"2418_CR19","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1080\/09273948.2023.2282609","volume":"31","author":"JR Smith","year":"2023","unstructured":"Smith\u00a0JR, Mochizuki\u00a0M (2023) Sarcoid uveitis in children. Ocul Immunol Inflamm 31:1965\u20131970. https:\/\/doi.org\/10.1080\/09273948.2023.2282609","journal-title":"Ocul Immunol Inflamm"},{"key":"2418_CR20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/pde.16001","volume":"42","author":"OJE Wang","year":"2025","unstructured":"Wang\u00a0OJE, Jacob\u00a0M, Crawford\u00a0RI, Lam\u00a0JM (2025) Blau syndrome: state-of-the-art review. Pediatr Dermatol 42:728\u2013734. https:\/\/doi.org\/10.1111\/pde.16001","journal-title":"Pediatr Dermatol"},{"key":"2418_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-023-00364-z","volume":"13","author":"M Bazewicz","year":"2023","unstructured":"Bazewicz\u00a0M, Heissigerova\u00a0J, Pavesio\u00a0C, Willermain\u00a0F, Skrzypecki\u00a0J (2023) Ocular sarcoidosis in adults and children. J\u00a0Ophthalmic Inflamm Infect 13:41. https:\/\/doi.org\/10.1186\/s12348-023-00364-z","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2418_CR22","first-page":"44","volume":"36","author":"J Sota","year":"2018","unstructured":"Sota\u00a0J et\u00a0al (2018) Eye involvement in monogenic autoinflammatory diseases. Clin Exp Rheumatol 36:44\u201353","journal-title":"Clin Exp Rheumatol"},{"key":"2418_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0002-9343(75)90390-3","volume":"59","author":"RS Dobrin","year":"1975","unstructured":"Dobrin\u00a0RS, Vernier\u00a0RL, Fish\u00a0AJ (1975) Acute eosinophilic interstitial nephritis with anterior uveitis. Am J Med 59:325\u2013333","journal-title":"Am J Med"},{"key":"2418_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/978-3-662-60399-4_25","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"K Brandauer","year":"2021","unstructured":"Brandauer\u00a0K, Zeisbrich\u00a0M, Schwenger\u00a0V, Mackensen\u00a0F (2021) TINU-Syndrom. In: Pleyer\u00a0U (ed) Entz\u00fcndliche Augenerkrankungen. Springer, pp\u00a0519\u2013525"},{"key":"2418_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-025-00500-x","volume":"15","author":"R Farnan","year":"2025","unstructured":"Farnan\u00a0R, Stokes\u00a0J, Casey\u00a0R, Byrne\u00a0AM, Leavey\u00a0S (2025) Tubulointerstitial nephritis and uveitis: case series. J\u00a0Ophthalmic Inflamm Infect 15:55. https:\/\/doi.org\/10.1186\/s12348-025-00500-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2418_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04535-z","volume":"26","author":"D Yang","year":"2025","unstructured":"Yang\u00a0D, Xi\u00a0W, Liu\u00a0W, Cheung\u00a0WW, Zhang\u00a0J (2025) Adalimumab in refractory pediatric TINU: case report. BMC Nephrol 26:609. https:\/\/doi.org\/10.1186\/s12882-025-04535-z","journal-title":"BMC Nephrol"},{"key":"2418_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki\u00a0T, Kosaki\u00a0F, Okawa\u00a0S, Shigematsu\u00a0I, Yanagawa\u00a0H (1974) Infantile acute febrile mucocutaneous lymph node syndrome. Pediatrics 54:271\u2013276","journal-title":"Pediatrics"},{"key":"2418_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-05133-y","volume":"24","author":"KO Ko","year":"2024","unstructured":"Ko\u00a0KO, Cheon\u00a0EJ (2024) Anterior uveitis as early diagnostic marker in incomplete Kawasaki disease. BMC Pediatr 24:644. https:\/\/doi.org\/10.1186\/s12887-024-05133-y","journal-title":"BMC Pediatr"},{"key":"2418_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-025-01143-x","volume":"23","author":"G Inguscio","year":"2025","unstructured":"Inguscio\u00a0G, Romano\u00a0S, Fabi\u00a0M et\u00a0al (2025) Anakinra for infants with Kawasaki disease and coronary lesions. Pediatr Rheumatol Online J 23:123. https:\/\/doi.org\/10.1186\/s12969-025-01143-x","journal-title":"Pediatr Rheumatol"},{"key":"2418_CR30","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1080\/09273948.2023.2271988","volume":"31","author":"P Gentile","year":"2023","unstructured":"Gentile\u00a0P, Ragusa\u00a0E, Bolletta\u00a0E, De Simone\u00a0L, Gozzi\u00a0F, Cappella\u00a0M et\u00a0al (2023) Epidemiology of pediatric uveitis. Ocul Immunol Inflamm 31:2050\u20132059. https:\/\/doi.org\/10.1080\/09273948.2023.2271988","journal-title":"Ocul Immunol Inflamm"},{"key":"2418_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/09273948.2024.2408411","volume":"33","author":"S Besagar","year":"2025","unstructured":"Besagar\u00a0S, de-la-Torre\u00a0A, Thorne\u00a0J, Biswas\u00a0J, Agrawal\u00a0R, Suhler\u00a0EB, Kempen\u00a0JH, Gangaputra\u00a0S (2025) Epidemiology of intermediate uveitis. Ocul Immunol Inflamm 33:503\u2013511. https:\/\/doi.org\/10.1080\/09273948.2024.2408411","journal-title":"Ocul Immunol Inflamm"},{"key":"2418_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03197-5","volume":"23","author":"C Azri","year":"2023","unstructured":"Azri\u00a0C, Dusser\u00a0P, Eid\u00a0L, Barreau\u00a0E, Kone-Paut\u00a0I, Borocco\u00a0C et\u00a0al (2023) Ocular involvement in pediatric Beh\u00e7et\u2019s disease. BMC Ophthalmol 23:474. https:\/\/doi.org\/10.1186\/s12886-023-03197-5","journal-title":"BMC Ophthalmol"},{"key":"2418_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1217711","volume":"3","author":"CH Choo","year":"2023","unstructured":"Choo\u00a0CH, Acharya\u00a0NR, Shantha\u00a0JG et\u00a0al (2023) Practice patterns in VKH diagnosis and management. Front Ophthalmol 3:1217711. https:\/\/doi.org\/10.3389\/fopht.2023.1217711","journal-title":"Front Ophthalmol"},{"key":"2418_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ajo.2021.03.036","volume":"228","author":"SUN Working Group","year":"2021","unstructured":"SUN Working Group (2021) Classification criteria for Vogt-Koyanagi-Harada disease. AJO Int 228:205\u2013211. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.036","journal-title":"Am J Ophthalmol"},{"key":"2418_CR35","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","volume":"78","author":"F Zulian","year":"2019","unstructured":"Zulian\u00a0F, Culpo\u00a0R, Sperotto\u00a0F, Anton\u00a0J, Avcin\u00a0T, Baildam\u00a0EM et\u00a0al (2019) Management of juvenile localized scleroderma. Ann Rheum Dis 78:1019\u20131024","journal-title":"Ann Rheum Dis"},{"key":"2418_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","volume":"49","author":"A Heiligenhaus","year":"2019","unstructured":"Heiligenhaus\u00a0A, Minden\u00a0K, Tappeiner\u00a0C, Baus\u00a0H, Bertram\u00a0B, Deuter\u00a0C et\u00a0al (2019) Update of the interdisciplinary guideline for anti-inflammatory treatment of JIA-associated uveitis. Semin Arthritis Rheum 49:43\u201355. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.004","journal-title":"Semin Arthritis Rheum"},{"key":"2418_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/acr.24963","volume":"75","author":"I Foeldvari","year":"2023","unstructured":"Foeldvari\u00a0I, Maccora\u00a0I, Petrushkin\u00a0H, Rahman\u00a0N, Anton\u00a0J, de Boer\u00a0J et\u00a0al (2023) Updated recommendations for treatment of JIA-associated uveitis. Arthritis Care Res 75:975\u2013982. https:\/\/doi.org\/10.1002\/acr.24963","journal-title":"Arthritis Care Res"},{"key":"2418_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-14","volume":"15","author":"AV Ramanan","year":"2014","unstructured":"Ramanan\u00a0AV, Dick\u00a0AD, Benton\u00a0D, Compeyrot-Lacassagne\u00a0S, Dawoud\u00a0D, Hardwick\u00a0B et\u00a0al (2014) Adalimumab plus methotrexate for JIA-associated uveitis: SYCAMORE trial. Trials 15:14. https:\/\/doi.org\/10.1186\/1745-6215-15-14","journal-title":"Trials"},{"key":"2418_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122782","volume":"12","author":"LS Zur Bonsen","year":"2024","unstructured":"Zur Bonsen\u00a0LS, Knecht\u00a0VA, R\u00fcbsam\u00a0A, Pohlmann\u00a0D, Pleyer\u00a0U (2024) Adalimumab autoantibodies in uveitis: need for drug monitoring? Biomedicines 12:2782. https:\/\/doi.org\/10.3390\/biomedicines12122782","journal-title":"Biomedicines"},{"key":"2418_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0648-3","volume":"17","author":"S Winterhalter","year":"2017","unstructured":"Winterhalter\u00a0S, Behrens\u00a0UD, Salchow\u00a0D, Joussen\u00a0AM, Pleyer\u00a0U (2017) Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series. BMC Ophthalmol 17:252. https:\/\/doi.org\/10.1186\/s12886-017-0648-3","journal-title":"BMC Ophthalmol"},{"key":"2418_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2023.04.011","volume":"130","author":"Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee","year":"2023","unstructured":"Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee (2023) Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results. Ophthalmol Sci 130:914\u2013923. https:\/\/doi.org\/10.1016\/j.ophtha.2023.04.011","journal-title":"Ophthalmology"},{"key":"2418_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00742-2","volume":"20","author":"K Mikola","year":"2022","unstructured":"Mikola\u00a0K, Rebane\u00a0K, Arnstad\u00a0ED, Berntson\u00a0L, Fasth\u00a0A, Glerup\u00a0M et\u00a0al (2022) Transitioning patients with JIA to adult care: Nordic experience. Pediatr Rheumatol 20:84","journal-title":"Pediatr Rheumatol"},{"key":"2418_CR43","doi-asserted-by":"crossref","unstructured":"Luque Ramos A, Hoffmann F, Albrecht K, Klotsche J, Zink A, Minden K. (2017) Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum. 47: 269-275. doi: 10.1016.","DOI":"10.1016\/j.semarthrit.2017.05.003"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-026-02418-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:30:26Z","timestamp":1775640626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-026-02418-8"}},"subtitle":["Klinik, Diagnostik, Therapie und Transition","Clinical aspects, diagnostics, treatment and transition"],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1007\/s00347-026-02418-8","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"U.\u00a0Pleyer\n                      : A. Finanzielle Interessen: Deutsche Forschungsgemeinschaft, BMBF, European Union.\u00a0\u2013 Honorare: AbbVie, Alcon, Allergan, Alimera, Bausch und Lomb, Bayer, Novartis, Santen, Thea | Vortragshonorar.\u00a0\u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u202f\u00c4.: AbbVie: Erstellung Webinar.\u00a0\u2013 B. Nichtfinanzielle Interessen: Oberarzt, Klinik f\u00fcr Augenheilkunde, Charit\u00e9 Universit\u00e4tsmedizin Berlin | Mitgliedschaft\/Funktion in Interessenverb\u00e4nden: Sprecher der Sektion: Uveitis\/DOG seit 2014, Schwerpunkt wissenschaftlicher klinischer T\u00e4tigkeiten: Leiter der Sprechstunde \u201eTerti\u00e4rzentrum f\u00fcr entz\u00fcndliche Augenerkrankungen\u201c 1994 bis heute, bis 2022 Sekret\u00e4r: Berlin-Brandenburgische Augen\u00e4rzte, bis 2022 Vorstandsmitglied: Deutsche UVEITIS Arbeitsgemeinschaft DUAG e.\u202fV. | U.\u00a0Pleyer ist Mitglied des Herausgeberboards von\n                      Die Ophthalmologie\n                      . Er war nicht an der Begutachtung dieses Manuskripts oder an Entscheidungen in Bezug auf dieses Manuskript beteiligt.\n                      L.\u00a0zur Bonsen\n                      : A. Finanzielle Interessen: Forschungsf\u00f6rderung DOG-Sektion Uveitis 2022\/2024. \u2013 Honorar Referentin: Novartis, Abbvie; Kostenerstattung Fortbildung: Alimera. \u2013 B. Nichtfinanzielle Interessen: Angestellte Augen\u00e4rztin, Klinik f\u00fcr Augenheilkunde, Charit\u00e9 Universit\u00e4tsmedizin Berlin | Mitgliedschaften: Deutsche Ophthalmologische Gesellschaft, Berlin-Brandenburgische Augen\u00e4rztliche Gesellschaft, European Academy of Allergy & Clinical Immunology.\n                      I.\u00a0Foeldvari\n                      : A. Finanzielle Interessen: Abbie EULAR meeting; Novarits PRES meeiting. \u2013 B. Nichtfinanzielle Interessen: Selbst\u00e4ndig | Migliedschaften: Pediatirc Rheumaotlogy Eurepean Sociaty, Amterican College of Rheumatology, Deutsche Gesellschaft f\u00fcr Kinderrheumatologie, Deutsche Gesellschaft f\u00fcr Rheumatologie, Scleroderma Clinical Trial Consortium.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}